{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:08:29Z","timestamp":1787620109127,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-68\/2022-14\/200161"],"award-info":[{"award-number":["451-03-68\/2022-14\/200161"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11096-023-01603-y","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T09:02:27Z","timestamp":1686128547000},"page":"989-998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2974-4535","authenticated-orcid":false,"given":"Tanja","family":"Tomic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7922-7691","authenticated-orcid":false,"given":"Martin","family":"Henman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5488-9261","authenticated-orcid":false,"given":"Ivana","family":"Tadic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-4368","authenticated-orcid":false,"given":"Jelena","family":"Antic Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0684-359X","authenticated-orcid":false,"given":"Milena","family":"Santric Milicevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Maksimovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-8361","authenticated-orcid":false,"given":"Marina","family":"Odalovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"issue":"8","key":"1603_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2471\/BLT.16.181743","volume":"94","author":"T Jinks","year":"2016","unstructured":"Jinks T, Lee N, Sharland M, et al. A time for action: antimicrobial resistance needs global response. Bull World Health Organ. 2016;94(8):558-558A. https:\/\/doi.org\/10.2471\/BLT.16.181743.","journal-title":"Bull World Health Organ"},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fphar.2016.00018","volume":"7","author":"M Jakovljevic","year":"2016","unstructured":"Jakovljevic M, Lazarevic M, Milovanovic O, et al. The new and old Europe: east-west split in pharmaceutical spending. Front Pharmacol. 2016;7:18. https:\/\/doi.org\/10.3389\/fphar.2016.00018.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1603_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, H\u00f6gberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population level modelling analysis. Lancet Infect Dis. 2019;19(1):56\u201366. https:\/\/doi.org\/10.1016\/S1473-3099(18)30605-4.","journal-title":"Lancet Infect Dis"},{"key":"1603_CR4","unstructured":"World Health Organization. Central Asian and Eastern European surveillance of antimicrobial resistance. CAESAR Annual report, 2019. https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0003\/418863\/53373-WHO-CAESAR-annual-report-2019.pdf. Accessed 21 Dec 2021."},{"issue":"Suppl 1","key":"1603_CR5","first-page":"8","volume":"30","author":"P Ruiz-Garbajosa","year":"2017","unstructured":"Ruiz-Garbajosa P, Cant\u00f3n R. Epidemiology of antibiotic resistance in Pseudomonas aeruginosa Implications for empiric and definitive therapy. Rev Esp Quimioter. 2017;30(Suppl 1):8\u201312.","journal-title":"Rev Esp Quimioter"},{"key":"1603_CR6","doi-asserted-by":"publisher","DOI":"10.1596\/31951","volume-title":"Republic of Serbia: National antibiotic resistance control programme for the period 2019\u20132021","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Republic of Serbia: National antibiotic resistance control programme for the period 2019\u20132021. Switzerland: World Health Organization; 2019."},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/antibiotics12020259","volume":"12","author":"D Medic","year":"2023","unstructured":"Medic D, Bozic Cvijan B, Bajcetic M. Impact of antibiotic consumption on antimicrobial resistance to invasive hospital pathogens. Antibiotics. 2023;12:259. https:\/\/doi.org\/10.3390\/antibiotics12020259.","journal-title":"Antibiotics"},{"key":"1603_CR8","unstructured":"European centre for disease prevention and control (ECDC). TESSy, The European surveillance system \u2013 antimicrobial consumption (AMC) reporting protocol 2023 \u2013 European surveillance of antimicrobial consumption network (ESAC-Net) surveillance data for 2022. Stockholm: ECDC; 2023. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/esac-net-reporting-protocol-2023. Accessed 15 Dec 2021."},{"key":"1603_CR9","unstructured":"Working group for the development of a national guide to good clinical practice for the rational use of antibiotics, Ministry of health of Republic of Serbia. National guide to good clinical practice for the rational use of antibiotics. Belgrade; 2018. https:\/\/www.zdravlje.gov.rs\/view_file.php?file_id=527&cache=sr. Accessed 15 Dec 2021."},{"key":"1603_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/antibiotics10040397","volume":"10","author":"A Tomas","year":"2021","unstructured":"Tomas A, Pavlovi\u0107 N, Stilinovi\u0107 N, et al. Increase and change in the pattern of antibiotic use in Serbia (2010\u20132019). Antibiotics. 2021;10:397. https:\/\/doi.org\/10.3390\/antibiotics10040397.","journal-title":"Antibiotics"},{"issue":"7","key":"1603_CR11","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/cid\/ciz409","volume":"70","author":"EM Krantz","year":"2020","unstructured":"Krantz EM, Zier J, Stohs E, et al. Antibiotic prescribing and respiratory viral testing for acute upper respiratory infections among adult patients at an ambulatory cancer center. Clin Infect Dis. 2020;70(7):1421\u20138. https:\/\/doi.org\/10.1093\/cid\/ciz409.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1603_CR12","doi-asserted-by":"publisher","first-page":"e114644","DOI":"10.1371\/journal.pone.0114644","volume":"9","author":"JA Lukovic","year":"2014","unstructured":"Lukovic JA, Miletic V, Pekmezovic T, et al. Self-medication practices and risk factors for self-medication among medical students in Belgrade, Serbia. PLoS ONE. 2014;9(12):e114644. https:\/\/doi.org\/10.1371\/journal.pone.0114644.","journal-title":"PLoS ONE"},{"issue":"3","key":"1603_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11096-018-0624-x","volume":"40","author":"K Tripkovi\u0107","year":"2018","unstructured":"Tripkovi\u0107 K, Ne\u0161kovi\u0107 A, Jankovi\u0107 J, et al. Predictors of self-medication in Serbian adult population: cross-sectional study. Int J Clin Pharm. 2018;40(3):627\u201334. https:\/\/doi.org\/10.1007\/s11096-018-0624-x.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"1603_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11096-015-0071-x","volume":"37","author":"MP Kusturica","year":"2015","unstructured":"Kusturica MP, Tomic Z, Bukumiric Z, et al. Home pharmacies in Serbia: an insight into self-medication practice. Int J Clin Pharm. 2015;37(2):373\u20138. https:\/\/doi.org\/10.1007\/s11096-015-0071-x. (Epub 2015 Jan 24 PMID: 25616627).","journal-title":"Int J Clin Pharm"},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11096-017-0461-3","volume":"39","author":"A Tomas","year":"2017","unstructured":"Tomas A, Paut Kusturica M, Tomi\u0107 Z, et al. Self-medication with antibiotics in Serbian households: a case for action? Int J Clin Pharm. 2017;39:507\u201313. https:\/\/doi.org\/10.1007\/s11096-017-0461-3.","journal-title":"Int J Clin Pharm"},{"issue":"41","key":"1603_CR16","doi-asserted-by":"publisher","first-page":"20928","DOI":"10.2807\/1560-7917.es2014.19.41.20928","volume":"19","author":"S Earnshaw","year":"2014","unstructured":"Earnshaw S, Mancarella G, Mendez A, et al. European antibiotic awareness day technical advisory committee. European antibiotic awareness day collaborative group european antibiotic awareness day: a five-year perspective of Europe-wide actions to promote prudent use of antibiotics. Euro Surveill. 2014;19(41):20928. https:\/\/doi.org\/10.2807\/1560-7917.es2014.19.41.20928.","journal-title":"Euro Surveill"},{"key":"1603_CR17","unstructured":"Reports on turnover and use of medicines of the Medicines and medical devices agency of Serbia. https:\/\/www.alims.gov.rs\/ciril\/o-agenciji\/publikacije\/. Accessed 17 Aug 2022."},{"key":"1603_CR18","unstructured":"World Health Organization. WHO collaborating centre for drug statistics methodology, guidelines for ATC classification and DDD assignment 2023. Oslo, Norway, 2022. https:\/\/www.whocc.no\/filearchive\/publications\/2023_guidelines_web.pdf. Accessed 16 Mar 2023."},{"key":"1603_CR19","unstructured":"World Health Organization. Central Asian and Eastern European surveillance of antimicrobial resistance. CAESAR manual, version 3, 2019. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/346572\/WHO-EURO-2019-3583-43342-60804-eng.pdf?sequence=1&isAllowed=y. Accessed 22 Dec 2021."},{"key":"1603_CR20","unstructured":"World Health Organization (WHO). WHO access, watch, reserve (AWaRe) classification of antibiotics for evaluation and monitoring of use, 2021. Geneva: WHO; 2021 (WHO\/MHP\/HPS\/EML\/2021.04). Available from: https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification. Accessed 16 Mar 2023."},{"key":"1603_CR21","unstructured":"Reports on the resistance of invasive bacterial isolates to antimicrobial drugs of Institute of public health of Vojvodina. http:\/\/www.izjzv.org.rs\/. Accessed 26 Jul 2022."},{"key":"1603_CR22","unstructured":"World Health Organization. Central Asian and Eastern European surveillance of antimicrobial resistance. Annual report. 2018. https:\/\/apps.who.int\/iris\/handle\/10665\/324806. Accessed 3 Aug 2022."},{"key":"1603_CR23","unstructured":"World Health Organization. Central Asian and Eastern European surveillance of antimicrobial resistance. Annual report. 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/345873. Accessed 3 Aug 2022."},{"key":"1603_CR24","unstructured":"WHO Regional office for Europe\/European centre for disease prevention and control. Antimicrobial resistance surveillance in Europe 2022 \u2013 2020 data. https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289056687. Accessed 3 Aug 2022."},{"key":"1603_CR25","unstructured":"World Health Organization. Central Asian and Eastern European surveillance of antimicrobial resistance. Annual report. 2017. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/342131\/9789289052993-eng.pdf?sequence=1&isAllowed=y. Accessed 3 Aug 2022."},{"key":"1603_CR26","unstructured":"World Health Organization. Central Asian and Eastern European surveillance of antimicrobial resistance. Annual report. 2016. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/344085\/9789289052252-eng.pdf?sequence=2&isAllowed=y. Accessed 3 Aug 2022."},{"key":"1603_CR27","unstructured":"World Health Organization. Central Asian and Eastern European surveillance of antimicrobial resistance. Annual report. 2014. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/344413\/9789289051088-eng.pdf?sequence=1&isAllowed=y. Accessed 3 Aug 2022."},{"key":"1603_CR28","unstructured":"Antimicrobial resistance dashboard. Copenhagen: WHO regional office for Europe; 2022 https:\/\/worldhealthorg.shinyapps.io\/WHO-AMR-Dashboard-main\/. Accessed 15 Mar 2023."},{"key":"1603_CR29","unstructured":"Reports on turnover and use of medicines of the agency for medicinal products and medical devices of Croatia. https:\/\/www.halmed.hr\/Promet-proizvodnja-i-inspekcija\/Promet\/Potrosnja-lijekova\/Izvjesca-o-prometu-lijekova\/. Accessed 17 Aug 2022."},{"key":"1603_CR30","unstructured":"European centre for disease prevention and control. Latest surveillance data on antimicrobial consumption. Antimicrobial consumption dashboard (ESAC-Net). AMC | European Centre for Disease Prevention and Control. https:\/\/qap.ecdc.europa.eu\/public\/extensions\/AMC2_Dashboard\/AMC2_Dashboard.html#eu-consumption-tab. Accessed 8 Mar 2023."},{"key":"1603_CR31","unstructured":"European centre for disease prevention and control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - annual Epidemiological report 2019. Country summaries - antimicrobial resistance in the EU\/EEA 2019. Stockholm: ECDC; 2020. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Country%20summaries-AER-EARS-Net%20202019.pdf. Accessed 15 Mar 2023."},{"key":"1603_CR32","unstructured":"European centre for disease prevention and control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - annual epidemiological report 2020. Country summaries - antimicrobial resistance in the EU\/EEA 2020. Stockholm: ECDC; 2022. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_EARS-Net%202020%20country-summaries.pdf. Accessed 15 Mar 2023."},{"key":"1603_CR33","unstructured":"Reports on turnover and use of medicines of Institute for medicines and medical devices of Montenegro. https:\/\/www.cinmed.me\/. Accessed 17 Aug 2022."},{"issue":"3","key":"1603_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z.Erratum.In:StatMed2001Feb28;20(4):655","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z.Erratum.In:StatMed2001Feb28;20(4):655. (PMID: 10649300).","journal-title":"Stat Med"},{"issue":"1","key":"1603_CR35","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1038\/s41598-019-40806-0","volume":"9","author":"I Dragomirescu","year":"2019","unstructured":"Dragomirescu I, Llorca J, G\u00f3mez IA, et al. A join point regression analysis of trends in mortality due to osteoporosis in Spain. Sci Rep. 2019;9(1):4264. https:\/\/doi.org\/10.1038\/s41598-019-40806-0.","journal-title":"Sci Rep"},{"key":"1603_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/antibiotics11070847","volume":"11","author":"A Despotovi\u0107","year":"2022","unstructured":"Despotovi\u0107 A, Bara\u0107 A, Cucani\u0107 T, et al. Antibiotic (Mis) use in COVID-19 patients before and after admission to a tertiary hospital in Serbia. Antibiotics. 2022;11:847. https:\/\/doi.org\/10.3390\/antibiotics11070847.","journal-title":"Antibiotics"},{"issue":"5","key":"1603_CR37","doi-asserted-by":"publisher","first-page":"e0175689","DOI":"10.1371\/journal.pone.0175689","volume":"12","author":"V Zivanovic","year":"2017","unstructured":"Zivanovic V, Bukarica LG, Scepanovic R, et al. Differences in antimicrobial consumption, prescribing and isolation rate of multidrug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii on surgical and medical wards. PLoS ONE. 2017;12(5):e0175689. https:\/\/doi.org\/10.1371\/journal.pone.0175689.","journal-title":"PLoS ONE"},{"key":"1603_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4274\/balkanmedj.2016.1844","volume":"34","author":"ZM Djordjevic","year":"2017","unstructured":"Djordjevic ZM, Folic MM, Jankovic SM. Previous antibiotic exposure and antimicrobial resistance patterns of Acinetobacter spp and Pseudomonas aeruginosa isolated from patients with nosocomial infections. Balkan Med J. 2017;34:527\u201333. https:\/\/doi.org\/10.4274\/balkanmedj.2016.1844.","journal-title":"Balkan Med J"},{"issue":"7","key":"1603_CR39","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/ajt.13893","volume":"16","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Fridkin SK, Aponte-Torres Z, et al. Vital signs: preventing antibiotic-resistant infections in hospitals - United States, 2014. Am J Transp. 2016;16(7):2224\u201330. https:\/\/doi.org\/10.1111\/ajt.13893.","journal-title":"Am J Transp"},{"issue":"3","key":"1603_CR40","first-page":"197","volume":"39","author":"A Mancini","year":"2016","unstructured":"Mancini A, Verdini D, La Vigna G, et al. Retrospective analysis of nosocomial infections in an Italian tertiary care hospital. New Microbiol. 2016;39(3):197\u2013205.","journal-title":"New Microbiol"},{"issue":"7","key":"1603_CR41","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/jac\/dkr167","volume":"66","author":"N Goel","year":"2011","unstructured":"Goel N, Wattal C, Oberoi JK, et al. Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi. India J Antimicrob Chemother. 2011;66(7):1625\u201330. https:\/\/doi.org\/10.1093\/jac\/dkr167.","journal-title":"India J Antimicrob Chemother"},{"key":"1603_CR42","unstructured":"European centre for disease prevention and control. Surveillance of antimicrobial resistance in Europe \u2013 annual report of the European antimicrobial resistance surveillance network (EARS-Net) 2017. Stockholm: ECDC; 2018. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AMR%202017_Cover%2BInner-web_v3.pdf. Accessed 20 Dec 2021."},{"key":"1603_CR43","unstructured":"European centre for disease prevention and control. Antimicrobial resistance surveillance in Europe 2015. Annual report of the European antimicrobial resistance surveillance network (EARS-Net). Stockholm: ECDC; 2017. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/antimicrobial-resistance-europe-2015.pdf. Accessed 20 Dec 2021."},{"issue":"5","key":"1603_CR44","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/jcpt.12432","volume":"41","author":"S Mladenovic-Antic","year":"2016","unstructured":"Mladenovic-Antic S, Kocic B, Velickovic-Radovanovic R, et al. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study. J Clin Pharm Ther. 2016;41(5):532\u20137. https:\/\/doi.org\/10.1111\/jcpt.12432.","journal-title":"J Clin Pharm Ther"},{"issue":"46","key":"1603_CR45","doi-asserted-by":"publisher","first-page":"1900656","DOI":"10.2807\/1560-7917.ES.2019.24.46.1900656","volume":"24","author":"G Pe\u00f1alva","year":"2019","unstructured":"Pe\u00f1alva G, H\u00f6gberg LD, Weist K, et al. Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union\/European Economic Area, 2001 to 2018. Euro Surveill. 2019;24(46):1900656. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.46.1900656.","journal-title":"Euro Surveill"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-023-01603-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T16:46:01Z","timestamp":1744130761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-023-01603-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1007\/s11096-023-01603-y","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}